Rab4 interacts with the human P-glycoprotein and modulates its surface expression in multidrug resistant K562 cells - PubMed (original) (raw)
. 2011 Jan 1;128(1):192-205.
doi: 10.1002/ijc.25310.
Affiliations
- PMID: 20209493
- DOI: 10.1002/ijc.25310
Rab4 interacts with the human P-glycoprotein and modulates its surface expression in multidrug resistant K562 cells
Clotilde Ferrándiz-Huertas et al. Int J Cancer. 2011.
Abstract
P-glycoprotein (P-gp) is a plasma membrane glycoprotein that has been signaled as a primary cause of multidrug resistance (MDR) in tumors. We performed a yeast 2-hybrid screen using the C-terminal domain of P-gp and identified 2 small GTPases involved in vesicular trafficking, Rab4 and Rab14, which complex with P-gp. The overexpression of GFP-Rab4, either transiently or stably, but not of Rab14, in K562ADR cells decreased the presence of P-gp in the cell surface. As a result, expression of this GTPase reduced the MDR phenotype of K562ADR cells, by augmenting the intracellular accumulation of daunomycin (DNM). This effect was mimicked by the constitutively active Rab4Q72L mutant, but not by the dominant negative Rab4S27N mutant. Rab4 regulated excocytotic P-gp trafficking to the plasma membrane from intracellular compartments, and this modulation required the interaction of both proteins and the GTPase activity. Noteworthy, K562ADR cells exhibited a significant reduction of Rab4 levels, but not of other Rab GTPases, as compared with the sensitive parental cell line, suggesting that the development of the MDR phenotype in these cells involves upregulation of P-gp and a concomitant downregulation of proteins that regulate its surface expression. Attenuation of endogenous Rab4 levels in K562ADR by RNA interference enhanced the expression of P-gp in the cell surface, and reduced the uptake of DNM. Accordingly, these findings substantiate the notion that modulation of the temporal and spatial distribution of P-gp in cancer cells may be a valid therapeutic strategy to alleviate the MDR phenotype, and signal to Rab4 as a potential target.
Copyright © 2010 UICC.
Similar articles
- Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: Implications in multidrug resistance in cancer.
Fu D, Bebawy M, Kable EP, Roufogalis BD. Fu D, et al. Int J Cancer. 2004 Mar 20;109(2):174-81. doi: 10.1002/ijc.11659. Int J Cancer. 2004. PMID: 14750166 - Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
Munteanu E, Verdier M, Grandjean-Forestier F, Stenger C, Jayat-Vignoles C, Huet S, Robert J, Ratinaud MH. Munteanu E, et al. Biochem Pharmacol. 2006 Apr 14;71(8):1162-74. doi: 10.1016/j.bcp.2006.01.006. Epub 2006 Feb 24. Biochem Pharmacol. 2006. PMID: 16499877 - Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.
Fu D, Roufogalis BD. Fu D, et al. Am J Physiol Cell Physiol. 2007 Apr;292(4):C1543-52. doi: 10.1152/ajpcell.00068.2006. Epub 2006 Nov 22. Am J Physiol Cell Physiol. 2007. PMID: 17122416 - Regulation of G-protein-coupled receptor activity by rab GTPases.
Rosenfeld JL, Knoll BJ, Moore RH. Rosenfeld JL, et al. Recept Channels. 2002;8(2):87-97. Recept Channels. 2002. PMID: 12448790 Review. - RAB39A: a Rab small GTPase with a prominent role in cancer stemness.
Chano T, Avnet S. Chano T, et al. J Biochem. 2018 Jul 1;164(1):9-14. doi: 10.1093/jb/mvy041. J Biochem. 2018. PMID: 29648608 Review.
Cited by
- Intracellular trafficking of P-glycoprotein.
Fu D, Arias IM. Fu D, et al. Int J Biochem Cell Biol. 2012 Mar;44(3):461-4. doi: 10.1016/j.biocel.2011.12.009. Epub 2011 Dec 24. Int J Biochem Cell Biol. 2012. PMID: 22212176 Free PMC article. Review. - Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative.
González ML, Vera DMA, Laiolo J, Joray MB, Maccioni M, Palacios SM, Molina G, Lanza PA, Gancedo S, Rumjanek V, Carpinella MC. González ML, et al. Front Pharmacol. 2017 Apr 25;8:205. doi: 10.3389/fphar.2017.00205. eCollection 2017. Front Pharmacol. 2017. PMID: 28487651 Free PMC article. - TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis.
Liu BHM, Tey SK, Mao X, Ma APY, Yeung CLS, Wong SWK, Ng TH, Xu Y, Yao Y, Fung EYM, Tan KV, Khong PL, Ho DW, Ng IO, Tang AHN, Cai SH, Yun JP, Yam JWP. Liu BHM, et al. J Extracell Vesicles. 2021 Aug;10(10):e12135. doi: 10.1002/jev2.12135. Epub 2021 Aug 11. J Extracell Vesicles. 2021. PMID: 34401050 Free PMC article. - Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.
Fowers KD, Kopeček J. Fowers KD, et al. Macromol Biosci. 2012 Apr;12(4):502-14. doi: 10.1002/mabi.201100350. Epub 2012 Jan 25. Macromol Biosci. 2012. PMID: 22278817 Free PMC article. - Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane.
Phatak V, von Grabowiecki Y, Janus J, Officer L, Behan C, Aschauer L, Pinon L, Mackay H, Zanivan S, Norman JC, Kelly M, Le Quesne J, Muller PAJ. Phatak V, et al. Cell Death Dis. 2021 Feb 24;12(2):207. doi: 10.1038/s41419-021-03497-y. Cell Death Dis. 2021. PMID: 33627632 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous